About DRA
DRA is a company based in Vantaa (Finland) founded in 2002 was acquired by PharmaLex in August 2022. DRA offers products and services including Strategic and Scientific Consultancy, Pharmacovigilance Services, and Regulatory Affairs Services. DRA operates in a competitive market with competitors including OPEN Health, Target RWE, Abacus Medicine, Secura Bio and STATinMED Research, among others.
Products & Services of DRA
DRA offers a comprehensive portfolio of products and services, including Strategic and Scientific Consultancy, Pharmacovigilance Services, and Regulatory Affairs Services.
Provides strategic advice for pharmaceutical development and innovation.
Manages adverse event monitoring and risk assessment in healthcare.
Handles regulatory writing and agency interactions for approvals.
Apps and channels of DRA
its YouTube channel Cencora PharmaLex has 185 subscribers and 25 videos.
Videos from DRA
The most watched videos on DRA's YouTube channel, Cencora PharmaLex (185 subscribers). Click a video to play it here.
More on Cencora PharmaLex.
Investors in DRA
DRA has secured backing from 1 investor. Prominent investors backing the company include PharmaLex.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
CRO specializing in regulatory affairs and pharmacovigilance | 1998 | pharmalex.com | Mannheim, Germany |
Investor details for DRA
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of DRA
2 dated milestones of DRA across 20 years, from founding to its latest funding, stage changes and deals.
- Founded DRA is founded.
- Exit Acquired by PharmaLex.
Competitors of DRA
DRA operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as OPEN Health, Target RWE, Abacus Medicine, Secura Bio and STATinMED Research, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| openhealthgroup.com | 2016 | Marlow, United Kingdom | $5.28M | 297 | Provider of healthcare marketing services | |
| targetrwe.com | 2017 | Durham, United States | – | 116 | Marketing services to the pharmaceutical industry are provided. | |
| abacusmedicine.com | 2004 | Copenhagen, Denmark | $57.64M | 1,052 | Consulting services for market access, health economics and outcomes research | |
| securabio.com | 2018 | Henderson, United States | $55M | – | Consulting services for market access and health outcomes are provided. | |
| statinmed.com | 2007 | Ann Arbor, United States | – | – | Healthcare data analytics services provider | |
| hylant.com | 1935 | Toledo, United States | – | 849 | Offers business insurance, employee benefits, and risk consulting services worldwide. | |
| gba-group.com | 1975 | Hamburg, Germany | – | – | GBA Group is recognized as a leading life sciences service provider. | |
| nutrasource.ca | 2002 | Guelph, Canada | – | – | Marketing services are provided for healthcare, nutraceutical, and pharmaceutical sectors. |
Detailed competitors of DRA
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Dra
Complete news archive for DRA
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to DRA
10 companies that operate in the same segment as DRA (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Drug discovery and development services are provided to biopharma sector. | 1993 | Hamburg, Hamburg, Germany | USD 25 M | USD 926.33 M | 4,830 | |
Drug discovery and development services for small molecules are provided. | 2003 | Beijing, China | USD 320 M | – | 476 | |
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 255.15 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
Pharmaceutical products for treating multiple diseases are provided. | 1849 | New York, New York, United States | USD 8 M | USD 266.99 M | 1,770 | |
Provider of laboratory tests for physicians | 1969 | Burlington, Vermont, United States | – | USD 13.95 B | 70,000 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about DRA
DRA was founded in 2002.
DRA is headquartered in Vantaa, Finland.
DRA was established in 2002 and is based in Vantaa, Finland. Market access services are delivered to companies in the biopharma industry. Operations focus on supporting product launches, pricing strategies, and reimbursement processes. Expertise is applied across European markets, with emphasis on regulatory compliance and stakeholder engagement. The domain dra.fi serves as the primary online presence for these activities.
DRA's top competitors include OPEN Health, Abacus Medicine and Target RWE.
DRA offers Strategic and Scientific Consultancy, Pharmacovigilance Services, and Regulatory Affairs Services.
DRA has 1 investor. Key investors include PharmaLex.
DRA operates through Pharmalex Gmbh.
Yes. DRA was acquired by PharmaLex in August 2022.